Health Management Associates (HMA) announced today creation of the HMA Institute on Addiction (IOA), a division dedicated to supporting the national effort to build an evidence-based, patient-centered, and sustainable addiction treatment ecosystem.
68 Results found.
Three HMA clinicians author naltrexone formulations in correctional settings issue brief
HMA’s Donna Strugar-Fritsch, Shannon Robinson, MD and Scott Haga, PA-C, recently authored the issue brief, Naltrexone Formulations in Correctional Settings. This brief provides clinical, financial, and administrative information prisons and jails can use in deciding whether to keep detainees on extended release naltrexone (XR-NTX, or the brand Vivitrol) or switch them to oral naltrexone tablets in instances where detainees have been prescribed XR-NXT prior to incarceration.
Health Management Associates Names Douglas Elwell CEO; Charles (Chuck) Milligan Joins Firm as COO
Health Management Associates (HMA) announced today that Chief Operating Officer Douglas (Doug) L. Elwell will assume the role of Chief Executive Officer, effective Nov. 1.
Leaders in justice and child welfare systems explain how HMA-developed MAT training can keep families together
Focused on ongoing support and solutions for those living with opioid use disorder (OUD), Health Management Associates (HMA) has developed a robust web-based training program about addiction and its treatment in the criminal justice and child welfare systems, including access to, and continued use of, medications for addiction treatment (MAT).
Health Management Associates Acquires Health Policy Consulting Firm Burns & Associates
Today, Jay Rosen, founder and president of Health Management Associates (HMA), announced the firm’s acquisition of Burns & Associates, Inc., an Arizona-based health policy consulting firm that specializes in innovative approaches to the financing and delivery of health care and human services.
Health Management Associates, HealthEC Announce New Collaboration
Today, Jay Rosen, founder and president of Health Management Associates (HMA), and Arthur Kapoor, president and CEO of HealthEC, announced the two firms have engaged in an effort designed to accelerate improvements in healthcare service delivery and outcomes.
HMA announces cancellation of 2020 annual conference
Health Management Associates has made the decision to cancel its October 2020 conference on Trends in Publicly Sponsored Healthcare, given continuing developments concerning COVID-19 and out of an abundance of caution for the safety of attendees, speakers, and staff. Full refunds will be made to registered attendees and sponsors.
Early Bird Registration Expires July 29 for HMA Conference, October 26-27 in Chicago
Be sure to register soon for HMA’s conference on What’s Next for Medicaid, Medicare, and Publicly Sponsored Healthcare: How Payers, Providers, and States Are Navigating a Future of Opportunity and Uncertainty, October 26-27, at the Fairmont Chicago, Millennium Park. The Early Bird registration rate of $1595 per person expires on July 29. After that, the rate is $1795.
HMA-developed medications for addiction treatment (MAT) training for justice and child welfare now available online
Focused on ongoing support and solutions for those living with opioid use disorder (OUD), Health Management Associates (HMA) has developed a robust web-based training program about addiction and its treatment in the criminal justice and child welfare systems, including access to, and continued use of, medications for addiction treatment (MAT).
Optimizing buprenorphine prescribing capacity in jails and prisons
This week, our In Focus section discusses an issue brief prepared by Health Management Associates (HMA), Optimizing Capacity for Prescribing Buprenorphine in Jails and Prisons, authored by HMA Principals Shannon Robinson, MD and Donna Strugar-Fritsch, BSN, MPA, CCHP.
Webinar alert: Evidence-based treatment of opioid use disorder in correctional settings
HMA is cohosting a webinar with the National Commission on Correctional Health Care.
Opioid use disorder is a chronic brain disease with effective, evidence-based treatments, and is a condition protected by the Americans with Disabilities Act. Prisons and jails are expected, by national health care and justice organizations and by communities, to treat incarcerated persons with OUD in accordance with evidence-based practices. This webinar reviews the most current evidence-based care for opioid withdrawal and OUD treatment and provides clinicians with strategies to move correctional health practices into compliance with national and community standards.
HMA conference on trends in publicly sponsored healthcare
HMA Conference 2020
What’s Next for Medicaid, Medicare, and Publicly Sponsored Healthcare:
How Payers, Providers, and States Are Navigating a Future of Opportunity and Uncertainty
Pre-Conference Workshop: October 25
Conference: October 26-27
Location: Fairmont Chicago, Millennium Park